Industry Research Reports

Home > Reports > Medical Devices & Consumables > Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-10-23

Pages: 138 Pages

Report ld: 3351868

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Diabetic Lancets Market Size(US$)

CAGR 2024-2030

4.3%

Market Size,2030

USD 1,543

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 1,201 million

Market Forecast in 2030(Value)

US$ 1,543 million

CAGR

4.3%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

A diabetic lancet is a small, sharp device used to prick the skin, typically the fingertip, to obtain a drop of blood for blood glucose testing. It is a key tool in diabetes management, allowing individuals with diabetes to regularly monitor their blood sugar levels. Lancets are often used with blood glucose meters and are designed to minimize pain and discomfort during testing. They are available in different sizes and needle thicknesses to suit various skin types and sensitivity levels.

The global market for Diabetic Lancets was estimated to be worth US$ 1153 million in 2023 and is forecast to a readjusted size of US$ 1543 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.

Market Drivers:

Rising prevalence of diabetes: The global surge in diabetes cases, fueled by lifestyle changes, poor diets, and increasing obesity, has led to higher demand for blood sugar monitoring devices, including lancets.

Increased awareness about diabetes management: Governments and healthcare organizations are focusing on awareness campaigns about the importance of regular blood sugar monitoring, which boosts demand for self-monitoring devices and lancets.

Technological advancements: Continuous innovations in lancet design, such as painless, ultra-thin, and easy-to-use lancets, are attracting consumers who prefer comfortable and convenient blood sugar testing methods.

Aging population: Older adults are more prone to diabetes and require frequent blood sugar monitoring, thereby increasing the demand for lancets in healthcare settings.

Home healthcare trend: The growing preference for home-based healthcare and self-monitoring tools has led to a rise in the use of personal blood glucose monitoring systems, including lancets.

Increase in health expenditures: Higher healthcare spending by both individuals and governments is propelling the growth of diabetes-related products, especially in developing countries.

Market Challenges:

Risk of infections: Improper use of lancets or reusing them can lead to infections, which may deter some individuals from using these devices consistently.

Cost pressures: Lancet devices are often seen as a recurring expense for diabetes patients, which can be a financial burden, especially in low-income countries. This may limit market growth among economically disadvantaged populations.

Availability of alternatives: The development of non-invasive blood glucose monitoring systems (e.g., sensor-based or continuous glucose monitors) is a potential threat to lancet usage, as they reduce the need for frequent finger-pricking.

Regulatory hurdles: Stringent regulations and the need for approvals from healthcare authorities can slow down the launch of new and improved lancet technologies, limiting the pace of market growth.

Environmental concerns: Lancets are generally single-use items, and their disposal raises concerns about medical waste and environmental impact, which may affect their adoption if eco-friendliness becomes a critical factor for consumers or policymakers.

The classification of Lancets includes Ordinary Lancets and Safety Lancets. In 2023, Ordinary Lancets accounted for a share of 61.81% in the global Lancets market. With several hospitals and healthcare facilities converting to safety lancets, this market share is poised for declined. Americas is the largest consumption place, with a consumption market share nearly 40.77% in 2022. Following Americas, Europe is the second largest consumption place with the consumption market share of 30.34%.

This report aims to provide a comprehensive presentation of the global market for Diabetic Lancets, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diabetic Lancets by region & country, by Type, and by Application.

The Diabetic Lancets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Lancets.

MARKET SEGMENTATION

By Company

Roche
Lifescan
BD
Ascensia
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Cardinal Health
ICU Medical
Sarstedt
Sinocare
Yicheng
Yuwell

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Safety Lancets
Ordinary Lancets

Segment by Application

Hospital
Homecare
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Diabetic Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Diabetic Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Diabetic Lancets in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Diabetic Lancets Product Introduction

1.2 Global Diabetic Lancets Market Size Forecast

1.2.1 Global Diabetic Lancets Sales Value (2019-2030)

1.2.2 Global Diabetic Lancets Sales Volume (2019-2030)

1.2.3 Global Diabetic Lancets Sales Price (2019-2030)

1.3 Diabetic Lancets Market Trends & Drivers

1.3.1 Diabetic Lancets Industry Trends

1.3.2 Diabetic Lancets Market Drivers & Opportunity

1.3.3 Diabetic Lancets Market Challenges

1.3.4 Diabetic Lancets Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Diabetic Lancets Players Revenue Ranking (2023)

2.2 Global Diabetic Lancets Revenue by Company (2019-2024)

2.3 Global Diabetic Lancets Players Sales Volume Ranking (2023)

2.4 Global Diabetic Lancets Sales Volume by Company Players (2019-2024)

2.5 Global Diabetic Lancets Average Price by Company (2019-2024)

2.6 Key Manufacturers Diabetic Lancets Manufacturing Base and Headquarters

2.7 Key Manufacturers Diabetic Lancets Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Diabetic Lancets

2.9 Diabetic Lancets Market Competitive Analysis

2.9.1 Diabetic Lancets Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Diabetic Lancets Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Lancets as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Safety Lancets

3.1.2 Ordinary Lancets

3.2 Global Diabetic Lancets Sales Value by Type

3.2.1 Global Diabetic Lancets Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Diabetic Lancets Sales Value, by Type (2019-2030)

3.2.3 Global Diabetic Lancets Sales Value, by Type (%) (2019-2030)

3.3 Global Diabetic Lancets Sales Volume by Type

3.3.1 Global Diabetic Lancets Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Diabetic Lancets Sales Volume, by Type (2019-2030)

3.3.3 Global Diabetic Lancets Sales Volume, by Type (%) (2019-2030)

3.4 Global Diabetic Lancets Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Homecare

4.1.3 Other

4.2 Global Diabetic Lancets Sales Value by Application

4.2.1 Global Diabetic Lancets Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Diabetic Lancets Sales Value, by Application (2019-2030)

4.2.3 Global Diabetic Lancets Sales Value, by Application (%) (2019-2030)

4.3 Global Diabetic Lancets Sales Volume by Application

4.3.1 Global Diabetic Lancets Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Diabetic Lancets Sales Volume, by Application (2019-2030)

4.3.3 Global Diabetic Lancets Sales Volume, by Application (%) (2019-2030)

4.4 Global Diabetic Lancets Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Diabetic Lancets Sales Value by Region

5.1.1 Global Diabetic Lancets Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Diabetic Lancets Sales Value by Region (2019-2024)

5.1.3 Global Diabetic Lancets Sales Value by Region (2025-2030)

5.1.4 Global Diabetic Lancets Sales Value by Region (%), (2019-2030)

5.2 Global Diabetic Lancets Sales Volume by Region

5.2.1 Global Diabetic Lancets Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Diabetic Lancets Sales Volume by Region (2019-2024)

5.2.3 Global Diabetic Lancets Sales Volume by Region (2025-2030)

5.2.4 Global Diabetic Lancets Sales Volume by Region (%), (2019-2030)

5.3 Global Diabetic Lancets Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Diabetic Lancets Sales Value, 2019-2030

5.4.2 North America Diabetic Lancets Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Diabetic Lancets Sales Value, 2019-2030

5.5.2 Europe Diabetic Lancets Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Diabetic Lancets Sales Value, 2019-2030

5.6.2 Asia Pacific Diabetic Lancets Sales Value by Region (%), 2023 VS 2030

5.7 South America

5.7.1 South America Diabetic Lancets Sales Value, 2019-2030

5.7.2 South America Diabetic Lancets Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Diabetic Lancets Sales Value, 2019-2030

5.8.2 Middle East & Africa Diabetic Lancets Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Diabetic Lancets Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Diabetic Lancets Sales Value

6.2.1 Key Countries/Regions Diabetic Lancets Sales Value, 2019-2030

6.2.2 Key Countries/Regions Diabetic Lancets Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Diabetic Lancets Sales Value, 2019-2030

6.3.2 United States Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Diabetic Lancets Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Diabetic Lancets Sales Value, 2019-2030

6.4.2 Europe Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Diabetic Lancets Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Diabetic Lancets Sales Value, 2019-2030

6.5.2 China Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

6.5.3 China Diabetic Lancets Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Diabetic Lancets Sales Value, 2019-2030

6.6.2 Japan Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Diabetic Lancets Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Diabetic Lancets Sales Value, 2019-2030

6.7.2 South Korea Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Diabetic Lancets Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Diabetic Lancets Sales Value, 2019-2030

6.8.2 Southeast Asia Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Diabetic Lancets Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Diabetic Lancets Sales Value, 2019-2030

6.9.2 India Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

6.9.3 India Diabetic Lancets Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Roche

7.1.1 Roche Company Information

7.1.2 Roche Introduction and Business Overview

7.1.3 Roche Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.1.4 Roche Diabetic Lancets Product Offerings

7.1.5 Roche Recent Development

7.2 Lifescan

7.2.1 Lifescan Company Information

7.2.2 Lifescan Introduction and Business Overview

7.2.3 Lifescan Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.2.4 Lifescan Diabetic Lancets Product Offerings

7.2.5 Lifescan Recent Development

7.3 BD

7.3.1 BD Company Information

7.3.2 BD Introduction and Business Overview

7.3.3 BD Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.3.4 BD Diabetic Lancets Product Offerings

7.3.5 BD Recent Development

7.4 Ascensia

7.4.1 Ascensia Company Information

7.4.2 Ascensia Introduction and Business Overview

7.4.3 Ascensia Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.4.4 Ascensia Diabetic Lancets Product Offerings

7.4.5 Ascensia Recent Development

7.5 Abbott

7.5.1 Abbott Company Information

7.5.2 Abbott Introduction and Business Overview

7.5.3 Abbott Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.5.4 Abbott Diabetic Lancets Product Offerings

7.5.5 Abbott Recent Development

7.6 B. Braun

7.6.1 B. Braun Company Information

7.6.2 B. Braun Introduction and Business Overview

7.6.3 B. Braun Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.6.4 B. Braun Diabetic Lancets Product Offerings

7.6.5 B. Braun Recent Development

7.7 ARKRAY

7.7.1 ARKRAY Company Information

7.7.2 ARKRAY Introduction and Business Overview

7.7.3 ARKRAY Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.7.4 ARKRAY Diabetic Lancets Product Offerings

7.7.5 ARKRAY Recent Development

7.8 Terumo

7.8.1 Terumo Company Information

7.8.2 Terumo Introduction and Business Overview

7.8.3 Terumo Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.8.4 Terumo Diabetic Lancets Product Offerings

7.8.5 Terumo Recent Development

7.9 I-SENS

7.9.1 I-SENS Company Information

7.9.2 I-SENS Introduction and Business Overview

7.9.3 I-SENS Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.9.4 I-SENS Diabetic Lancets Product Offerings

7.9.5 I-SENS Recent Development

7.10 Nipro

7.10.1 Nipro Company Information

7.10.2 Nipro Introduction and Business Overview

7.10.3 Nipro Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.10.4 Nipro Diabetic Lancets Product Offerings

7.10.5 Nipro Recent Development

7.11 Cardinal Health

7.11.1 Cardinal Health Company Information

7.11.2 Cardinal Health Introduction and Business Overview

7.11.3 Cardinal Health Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.11.4 Cardinal Health Diabetic Lancets Product Offerings

7.11.5 Cardinal Health Recent Development

7.12 ICU Medical

7.12.1 ICU Medical Company Information

7.12.2 ICU Medical Introduction and Business Overview

7.12.3 ICU Medical Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.12.4 ICU Medical Diabetic Lancets Product Offerings

7.12.5 ICU Medical Recent Development

7.13 Sarstedt

7.13.1 Sarstedt Company Information

7.13.2 Sarstedt Introduction and Business Overview

7.13.3 Sarstedt Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.13.4 Sarstedt Diabetic Lancets Product Offerings

7.13.5 Sarstedt Recent Development

7.14 Sinocare

7.14.1 Sinocare Company Information

7.14.2 Sinocare Introduction and Business Overview

7.14.3 Sinocare Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.14.4 Sinocare Diabetic Lancets Product Offerings

7.14.5 Sinocare Recent Development

7.15 Yicheng

7.15.1 Yicheng Company Information

7.15.2 Yicheng Introduction and Business Overview

7.15.3 Yicheng Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.15.4 Yicheng Diabetic Lancets Product Offerings

7.15.5 Yicheng Recent Development

7.16 Yuwell

7.16.1 Yuwell Company Information

7.16.2 Yuwell Introduction and Business Overview

7.16.3 Yuwell Diabetic Lancets Sales, Revenue, Price and Gross Margin (2019-2024)

7.16.4 Yuwell Diabetic Lancets Product Offerings

7.16.5 Yuwell Recent Development

8 Industry Chain Analysis

8.1 Diabetic Lancets Industrial Chain

8.2 Diabetic Lancets Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Diabetic Lancets Sales Model

8.5.2 Sales Channel

8.5.3 Diabetic Lancets Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Diabetic Lancets Market Trends

Table 2. Diabetic Lancets Market Drivers & Opportunity

Table 3. Diabetic Lancets Market Challenges

Table 4. Diabetic Lancets Market Restraints

Table 5. Global Diabetic Lancets Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Diabetic Lancets Revenue Market Share by Company (2019-2024)

Table 7. Global Diabetic Lancets Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Diabetic Lancets Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Diabetic Lancets Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Diabetic Lancets Manufacturing Base and Headquarters

Table 11. Key Manufacturers Diabetic Lancets Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Diabetic Lancets

Table 13. Global Diabetic Lancets Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Lancets as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Diabetic Lancets Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Diabetic Lancets Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Diabetic Lancets Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Diabetic Lancets Sales Market Share in Value by Type (2019-2024)

Table 20. Global Diabetic Lancets Sales Market Share in Value by Type (2025-2030)

Table 21. Global Diabetic Lancets Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Diabetic Lancets Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Diabetic Lancets Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Diabetic Lancets Sales Market Share in Volume by Type (2019-2024)

Table 25. Global Diabetic Lancets Sales Market Share in Volume by Type (2025-2030)

Table 26. Global Diabetic Lancets Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Diabetic Lancets Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Diabetic Lancets Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Diabetic Lancets Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Diabetic Lancets Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Diabetic Lancets Sales Market Share in Value by Application (2019-2024)

Table 32. Global Diabetic Lancets Sales Market Share in Value by Application (2025-2030)

Table 33. Global Diabetic Lancets Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Diabetic Lancets Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Diabetic Lancets Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Diabetic Lancets Sales Market Share in Volume by Application (2019-2024)

Table 37. Global Diabetic Lancets Sales Market Share in Volume by Application (2025-2030)

Table 38. Global Diabetic Lancets Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Diabetic Lancets Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Diabetic Lancets Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)

Table 41. Global Diabetic Lancets Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Diabetic Lancets Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Diabetic Lancets Sales Value by Region (2019-2024) & (%)

Table 44. Global Diabetic Lancets Sales Value by Region (2025-2030) & (%)

Table 45. Global Diabetic Lancets Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Diabetic Lancets Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Diabetic Lancets Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Diabetic Lancets Sales Volume by Region (2019-2024) & (%)

Table 49. Global Diabetic Lancets Sales Volume by Region (2025-2030) & (%)

Table 50. Global Diabetic Lancets Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Diabetic Lancets Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Diabetic Lancets Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Diabetic Lancets Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Diabetic Lancets Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Diabetic Lancets Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Diabetic Lancets Sales Volume, (2025-2030) & (K Units)

Table 57. Roche Company Information

Table 58. Roche Introduction and Business Overview

Table 59. Roche Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Roche Diabetic Lancets Product Offerings

Table 61. Roche Recent Development

Table 62. Lifescan Company Information

Table 63. Lifescan Introduction and Business Overview

Table 64. Lifescan Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Lifescan Diabetic Lancets Product Offerings

Table 66. Lifescan Recent Development

Table 67. BD Company Information

Table 68. BD Introduction and Business Overview

Table 69. BD Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. BD Diabetic Lancets Product Offerings

Table 71. BD Recent Development

Table 72. Ascensia Company Information

Table 73. Ascensia Introduction and Business Overview

Table 74. Ascensia Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Ascensia Diabetic Lancets Product Offerings

Table 76. Ascensia Recent Development

Table 77. Abbott Company Information

Table 78. Abbott Introduction and Business Overview

Table 79. Abbott Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Abbott Diabetic Lancets Product Offerings

Table 81. Abbott Recent Development

Table 82. B. Braun Company Information

Table 83. B. Braun Introduction and Business Overview

Table 84. B. Braun Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. B. Braun Diabetic Lancets Product Offerings

Table 86. B. Braun Recent Development

Table 87. ARKRAY Company Information

Table 88. ARKRAY Introduction and Business Overview

Table 89. ARKRAY Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. ARKRAY Diabetic Lancets Product Offerings

Table 91. ARKRAY Recent Development

Table 92. Terumo Company Information

Table 93. Terumo Introduction and Business Overview

Table 94. Terumo Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Terumo Diabetic Lancets Product Offerings

Table 96. Terumo Recent Development

Table 97. I-SENS Company Information

Table 98. I-SENS Introduction and Business Overview

Table 99. I-SENS Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. I-SENS Diabetic Lancets Product Offerings

Table 101. I-SENS Recent Development

Table 102. Nipro Company Information

Table 103. Nipro Introduction and Business Overview

Table 104. Nipro Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Nipro Diabetic Lancets Product Offerings

Table 106. Nipro Recent Development

Table 107. Cardinal Health Company Information

Table 108. Cardinal Health Introduction and Business Overview

Table 109. Cardinal Health Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Cardinal Health Diabetic Lancets Product Offerings

Table 111. Cardinal Health Recent Development

Table 112. ICU Medical Company Information

Table 113. ICU Medical Introduction and Business Overview

Table 114. ICU Medical Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. ICU Medical Diabetic Lancets Product Offerings

Table 116. ICU Medical Recent Development

Table 117. Sarstedt Company Information

Table 118. Sarstedt Introduction and Business Overview

Table 119. Sarstedt Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Sarstedt Diabetic Lancets Product Offerings

Table 121. Sarstedt Recent Development

Table 122. Sinocare Company Information

Table 123. Sinocare Introduction and Business Overview

Table 124. Sinocare Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Sinocare Diabetic Lancets Product Offerings

Table 126. Sinocare Recent Development

Table 127. Yicheng Company Information

Table 128. Yicheng Introduction and Business Overview

Table 129. Yicheng Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Yicheng Diabetic Lancets Product Offerings

Table 131. Yicheng Recent Development

Table 132. Yuwell Company Information

Table 133. Yuwell Introduction and Business Overview

Table 134. Yuwell Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Yuwell Diabetic Lancets Product Offerings

Table 136. Yuwell Recent Development

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Diabetic Lancets Downstream Customers

Table 140. Diabetic Lancets Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Diabetic Lancets Product Picture

Figure 2. Global Diabetic Lancets Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Diabetic Lancets Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Diabetic Lancets Sales Volume (2019-2030) & (K Units)

Figure 5. Global Diabetic Lancets Sales Price (2019-2030) & (US$/Unit)

Figure 6. Diabetic Lancets Report Years Considered

Figure 7. Global Diabetic Lancets Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Diabetic Lancets Players Sales Volume Ranking (2023) & (US$ Million)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetic Lancets Revenue in 2023

Figure 10. Diabetic Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Safety Lancets Picture

Figure 12. Ordinary Lancets Picture

Figure 13. Global Diabetic Lancets Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Diabetic Lancets Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Diabetic Lancets Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Diabetic Lancets Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Diabetic Lancets Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Homecare

Figure 20. Product Picture of Other

Figure 21. Global Diabetic Lancets Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Diabetic Lancets Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Diabetic Lancets Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Diabetic Lancets Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Diabetic Lancets Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Diabetic Lancets Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Diabetic Lancets Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 29. Europe Diabetic Lancets Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Diabetic Lancets Sales Value by Region (%), 2023 VS 2030

Figure 32. South America Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 33. South America Diabetic Lancets Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Diabetic Lancets Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Diabetic Lancets Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Diabetic Lancets Sales Volume (%), (2019-2030)

Figure 38. United States Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Diabetic Lancets Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Diabetic Lancets Sales Value by Application (%), 2023 VS 2030

Figure 44. China Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

Figure 46. China Diabetic Lancets Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Diabetic Lancets Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Diabetic Lancets Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Diabetic Lancets Sales Value by Application (%), 2023 VS 2030

Figure 56. India Diabetic Lancets Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Diabetic Lancets Sales Value by Type (%), 2023 VS 2030

Figure 58. India Diabetic Lancets Sales Value by Application (%), 2023 VS 2030

Figure 59. Diabetic Lancets Industrial Chain

Figure 60. Diabetic Lancets Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Diabetic Lancets in 2024? zhanKai

The global market size of Diabetic Lancets in 2024 was 1201 Million USD.

What is the annual compound growth rate of the global Diabetic Lancets market size from 2024 to 2030? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Diabetic Lancets in 2030? shouQi

Which companies rank high in the global Diabetic Lancets market? shouQi

Related Reports

Global Diabetic Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Diabetic Lancets market is projected to grow from US$ 1247 million in 2025 to US$ 1664 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 179
USD 4900.00
(Single User License)
Global Diabetic Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetic Lancets market size was US$ 1247 million in 2025 and is forecast to reach a readjusted size of US$ 1664 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 108
USD 4250.00
(Single User License)
Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetic Lancets was estimated to be worth US$ 1247 million in 2025 and is projected to reach US$ 1664 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 132
USD 3950.00
(Single User License)
Global Diabetic Lancets Market Research Report 2026
The global Diabetic Lancets market was valued at US$ 1247 million in 2025 and is anticipated to reach US$ 1664 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 135
USD 2900.00
(Single User License)
Global Diabetic Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetic Lancets market is projected to grow from US$ 1201 million in 2024 to US$ 1603 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-23
Pages: 179
USD 4900.00
(Single User License)
Diabetic Lancets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetic Lancets was estimated to be worth US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-04-14
Pages: 149
USD 3950.00
(Single User License)
Global Diabetic Lancets Market Insights, Forecast to 2031
The global Diabetic Lancets market is projected to grow from US$ 1247 million in 2025 to US$ 1603 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Published Date: 2025-04-14
Pages: 180
USD 4900.00
(Single User License)
Global Diabetic Lancets Market Research Report 2025
The global market for Diabetic Lancets was valued at US$ 1201 million in the year 2024 and is projected to reach a revised size of US$ 1603 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-04-14
Pages: 107
USD 2900.00
(Single User License)
Global Diabetic Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetic Lancets market size was US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-04-14
Pages: 110
USD 4250.00
(Single User License)
Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetic Lancets was estimated to be worth US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-02-19
Pages: 131
USD 3950.00
(Single User License)

Global Diabetic Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Diabetic Lancets market is projected to grow from US$ 1247 million in 2025 to US$ 1664 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 179
USD 4900.00 (Single User License)
Global Diabetic Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetic Lancets market size was US$ 1247 million in 2025 and is forecast to reach a readjusted size of US$ 1664 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 108
USD 4250.00 (Single User License)
Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetic Lancets was estimated to be worth US$ 1247 million in 2025 and is projected to reach US$ 1664 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 132
USD 3950.00 (Single User License)
Global Diabetic Lancets Market Research Report 2026
The global Diabetic Lancets market was valued at US$ 1247 million in 2025 and is anticipated to reach US$ 1664 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 135
USD 2900.00 (Single User License)
Global Diabetic Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetic Lancets market is projected to grow from US$ 1201 million in 2024 to US$ 1603 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-23
Pages: 179
USD 4900.00 (Single User License)
Diabetic Lancets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetic Lancets was estimated to be worth US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-04-14
Pages: 149
USD 3950.00 (Single User License)
Global Diabetic Lancets Market Insights, Forecast to 2031
The global Diabetic Lancets market is projected to grow from US$ 1247 million in 2025 to US$ 1603 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Published: 2025-04-14
Pages: 180
USD 4900.00 (Single User License)
Global Diabetic Lancets Market Research Report 2025
The global market for Diabetic Lancets was valued at US$ 1201 million in the year 2024 and is projected to reach a revised size of US$ 1603 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-04-14
Pages: 107
USD 2900.00 (Single User License)
Global Diabetic Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetic Lancets market size was US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-04-14
Pages: 110
USD 4250.00 (Single User License)
Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetic Lancets was estimated to be worth US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-02-19
Pages: 131
USD 3950.00 (Single User License)